Major depressive disorder: hypothesis, mechanism, prevention and treatment

Большое депрессивное расстройство: гипотезы, механизмы, профилактика и лечение
Yijun Wang, Baoman Li, Yong Tang, Lulu Cui, Shu Li, Siman Wang, Xiafang Wu, Yingyu Liu, Weiyang Yu, Maosheng Xia
2024-02-08

HPA axisantidepressant treatmentcytokine hypothesismajor depressive disorderneuroplasticity
Worldwide, the incidence of major depressive disorder (MDD) is increasing annually, resulting in greater economic and social burdens. Moreover, the pathological mechanisms of MDD and the mechanisms underlying the effects of pharmacological treatments for MDD are complex and unclear, and additional diagnostic and therapeutic strategies for MDD still are needed. The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis, but these hypothesis cannot completely explain the pathological mechanism of MDD. Even it is still hard to adopt only one hypothesis to completely reveal the pathogenesis of MDD, thus in recent years, great progress has been made in elucidating the roles of multiple organ interactions in the pathogenesis MDD and identifying novel therapeutic approaches and multitarget modulatory strategies, further revealing the disease features of MDD. Furthermore, some newly discovered potential pharmacological targets and newly studied antidepressants have attracted widespread attention, some reagents have even been approved for clinical treatment and some novel therapeutic methods such as phototherapy and acupuncture have been discovered to have effective improvement for the depressive symptoms. In this work, we comprehensively summarize the latest research on the pathogenesis and diagnosis of MDD, preventive approaches and therapeutic medicines, as well as the related clinical trials.
1
Established MDD mechanisms—including neurotransmitter, HPA-axis, cytokine, neuroplasticity, and systemic hypotheses—cannot fully explain its pathogenesis individually.
2
Major depressive disorder incidence is increasing worldwide, creating growing economic and social burdens.
3
New pharmacological targets and antidepressants have emerged, with some agents receiving clinical approval.
4
Nonpharmacological approaches, including phototherapy and acupuncture, have shown improvement in depressive symptoms.
5
Recent research emphasizes interactions among multiple organs and supports multitarget modulatory strategies for understanding and treating MDD.

major depressive disorder (MDD)

its pathogenesis, diagnosis, prevention, and treatment, including underlying mechanisms and therapeutic strategies

Publication Details
Publication Date
2024-02-08
Journal
Publisher
ISSN
Cited by
1069
Access Type
Author Information
Authors
Yijun Wang
Baoman Li
Yong Tang
Lulu Cui
Shu Li
Siman Wang
Xiafang Wu
Yingyu Liu
Weiyang Yu
Maosheng Xia
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%